Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease.
about
Bipolar disorder and mechanisms of action of mood stabilizersRole of prostaglandins in neuroinflammatory and neurodegenerative diseasesRole of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson diseaseD2-like receptor activation does not initiate a brain docosahexaenoic acid signal in unanesthetized ratsStriatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomographyIn vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's diseaseKnocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brainChronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.The proteome of the differentiating mesencephalic progenitor cell line CSM14.1 in vitro.
P2860
Q22252332-261E4854-2827-416E-BBB0-D0CF1B991D0CQ26863534-39B9A5F4-69F5-4D72-81E5-67BEEB66247BQ33565825-30F800F4-DD75-495C-9440-0D875F0CFFA4Q33718730-69C3E67D-7182-4AA4-8A84-14F6D077B37DQ34967589-60FD3A61-4AF4-4087-94E1-A75100E30BE2Q35167540-EEB88A48-7C7B-4D8A-B395-B870E4EC6DA3Q35308508-EE46484C-E373-4AAB-9F22-0E423F8980A8Q35742545-0D80288B-5ED5-4E44-B006-1592B138E654Q35866847-081CABA4-2393-482F-9371-034C77470265Q36088214-2730A2C1-8C9E-467C-A389-CE386FD30A96Q36089003-4CAED3BA-E6EA-4100-8170-6A234AC424CBQ36296926-F84BE304-F6D7-4354-A011-7CDD5E78EAAEQ37178269-96365D18-7FA5-43CF-9F34-0B5810A12EFEQ37590122-83EE09F9-E59E-491F-B917-12F270A690FDQ39018803-344105A5-A9E0-47AA-BEE6-7B2F584859E7
P2860
Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Selective dopamine receptor st ...... model of Parkinson's disease.
@ast
Selective dopamine receptor st ...... model of Parkinson's disease.
@en
type
label
Selective dopamine receptor st ...... model of Parkinson's disease.
@ast
Selective dopamine receptor st ...... model of Parkinson's disease.
@en
prefLabel
Selective dopamine receptor st ...... model of Parkinson's disease.
@ast
Selective dopamine receptor st ...... model of Parkinson's disease.
@en
P2093
P1476
Selective dopamine receptor st ...... t model of Parkinson's disease
@en
P2093
S I Rapoport
T Hayakawa
P304
P407
P577
2001-03-01T00:00:00Z